Your browser doesn't support javascript.
Reply: Is high-dose glucocorticoid beneficial in COVID-19?
Edalatifard, Maryam; Akhtari, Maryam; Salehi, Mohammadreza; Farhadi, Elham; Jamshidi, Ahmadreza; Mahmoudi, Mahdi; Rostamian, Abdolrahman.
  • Edalatifard M; Advanced Thoracic Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Akhtari M; Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Salehi M; Inflammation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Farhadi E; Dept of Infectious and Tropical Medicines, Tehran University of Medical Sciences, Tehran, Iran.
  • Jamshidi A; Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Mahmoudi M; Inflammation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Rostamian A; Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Eur Respir J ; 57(4)2021 04.
Article in English | MEDLINE | ID: covidwho-1190027
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Glucocorticoids Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: 13993003.00324-2021

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Glucocorticoids Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: 13993003.00324-2021